Lead: Averted lung cancer deaths due to reductions in cigarette smoking in the United States, 1970–2022

Averted lung cancer deaths due to reductions in cigarette smoking in the United States, 1970–2022

Cancer

Smoking prevalence peaked in the 50s and 60s but has declined following the US Surgeon General’s report in 1964 on its health risk. As 85% of lung cancer is attributable to smoking, the authors evaluated this impact by assessing lung cancer deaths averted, and person-years of life (PYL) gained between 1970 and 2022 using cancer mortality data from the CDC. The authors estimated 3,856,240 lung cancer deaths were averted and 76,275,550 PYL were gained during the study period (average of 19.8 PYL gained per death averted). The deaths averted were higher in men (2,246,610), but average PYL gained per death averted was higher in women (22.4 years). Lung cancer deaths averted accounted for 51.4% of the estimated decrease in overall cancer deaths. The findings highlight the importance of tobacco controls and interventions and need for ongoing efforts to decrease tobacco use.

Read this issue of the ASAM Weekly

Subscribe to the ASAM Weekly

Visit ASAM